ArticleMolecular therapy. Nucleic acids2021

BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy.

Vanessa Strings-Ufombah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.